Peripheral T- and B-cell immune signatures in early Alzheimer’s disease

Background Neuroinflammation and peripheral adaptive immune dysregulation have been implicated in Alzheimer’s disease (AD), but whether peripheral immune alterations are detectable at the earliest biomarker-defined stages remains unclear. Most immunophenotyping studies enrolled patients with clinically manifest dementia without biomarker confirmation. Methods We conducted a prospective, observational, single-centre study in consecutive adults with normal cognition or mild cognitive impairment (MMSE >22; CDR 0–0.5). Participants were classified by CSF and blood biomarkers into biomarker-defined AD, other dementias (OD), and non-degenerative cognitive complaints (NDC). Peripheral blood surface-marker immunophenotyping by multiparametric flow cytometry characterised B-cell and T-cell compartments, including regulatory, conventional helper, follicular helper, and double-negative T-cell subsets. Groups were compared using Benjamini-Hochberg-adjusted parametric and non-parametric tests. Exploratory analyses included principal component analysis, permutational multivariate analysis of variance (PERMANOVA), correlations between immune subsets and AD biomarkers, and a logistic regression model discriminating AD from NDC, evaluated by ROC analysis. Results Seventy-nine participants were included (AD n=43, OD n=18, NDC n=18). No significant differences were detected in any lymphocyte population between biomarker-defined AD and NDC after multiple-testing correction. The clearest, albeit modest, multivariate separation was between AD and OD, driven by nominally higher frequencies of Th17-like regulatory T cells and Th9-like cells in OD that did not survive correction, except for Th17-like regulatory T cells in the age- and sex-adjusted AD-versus-OD comparison. Double-negative γδ T cells were numerically, but not significantly, lower in AD than in NDC, and an exploratory logistic model including double-negative T-cell subsets achieved moderate discrimination (AUC 0.743) without external validation. Correlations between immune subsets and AD biomarkers were weak; the most apparent was between Th17-like regulatory T cells and CSF neurofilament light chain, not amyloid-β or tau. Conclusions No significant differences in peripheral adaptive immune profiles were detected between biomarker-defined early AD and NDC, suggesting that overt peripheral immune activation is not yet established at the earliest stages of the Alzheimer’s continuum. The exploratory differences between AD and OD, involving Th17-like regulatory T cells and Th9-like cells, may reflect Treg plasticity and IL-9 axis activation in active neurodegeneration, warranting functional validation. These signatures should not be regarded as candidate biomarkers for early AD detection.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-13
DOI
https://doi.org/10.3389/fimmu.2026.2005691
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Peripheral T- and B-cell immune signatures in early Alzheimer’s disease

Lourdes Álvarez‐Sánchez, Víctor García-Bustos, Consuelo Cháfer‐Pericás, Marta Dafne Cabañero-Navalón et al.
3 links
Frontiers in Immunology
Dementia and Cognitive Impairment Research
article

Peripheral T- and B-cell immune signatures in early Alzheimer’s disease

Lourdes Álvarez‐Sánchez, Víctor García-Bustos, Consuelo Cháfer‐Pericás, Marta Dafne Cabañero-Navalón, Miguel Baquero, H. Martín, María Mercedes Díaz-Luna, Hernán Panos-Rubio, Marc Boigues
article en

Abstract

Background Neuroinflammation and peripheral adaptive immune dysregulation have been implicated in Alzheimer’s disease (AD), but whether peripheral immune alterations are detectable at the earliest biomarker-defined stages remains unclear. Most immunophenotyping studies enrolled patients with clinically manifest dementia without biomarker confirmation. Methods We conducted a prospective, observational, single-centre study in consecutive adults with normal cognition or mild cognitive impairment (MMSE >22; CDR 0–0.5). Participants were classified by CSF and blood biomarkers into biomarker-defined AD, other dementias (OD), and non-degenerative cognitive complaints (NDC). Peripheral blood surface-marker immunophenotyping by multiparametric flow cytometry characterised B-cell and T-cell compartments, including regulatory, conventional helper, follicular helper, and double-negative T-cell subsets. Groups were compared using Benjamini-Hochberg-adjusted parametric and non-parametric tests. Exploratory analyses included principal component analysis, permutational multivariate analysis of variance (PERMANOVA), correlations between immune subsets and AD biomarkers, and a logistic regression model discriminating AD from NDC, evaluated by ROC analysis. Results Seventy-nine participants were included (AD n=43, OD n=18, NDC n=18). No significant differences were detected in any lymphocyte population between biomarker-defined AD and NDC after multiple-testing correction. The clearest, albeit modest, multivariate separation was between AD and OD, driven by nominally higher frequencies of Th17-like regulatory T cells and Th9-like cells in OD that did not survive correction, except for Th17-like regulatory T cells in the age- and sex-adjusted AD-versus-OD comparison. Double-negative γδ T cells were numerically, but not significantly, lower in AD than in NDC, and an exploratory logistic model including double-negative T-cell subsets achieved moderate discrimination (AUC 0.743) without external validation. Correlations between immune subsets and AD biomarkers were weak; the most apparent was between Th17-like regulatory T cells and CSF neurofilament light chain, not amyloid-β or tau. Conclusions No significant differences in peripheral adaptive immune profiles were detected between biomarker-defined early AD and NDC, suggesting that overt peripheral immune activation is not yet established at the earliest stages of the Alzheimer’s continuum. The exploratory differences between AD and OD, involving Th17-like regulatory T cells and Th9-like cells, may reflect Treg plasticity and IL-9 axis activation in active neurodegeneration, warranting functional validation. These signatures should not be regarded as candidate biomarkers for early AD detection.

Frontiers in ImmunologyVol. 17
Universidad de Las Palmas de Gran Canaria (ES), Hospital Universitari i Politècnic La Fe (ES), Instituto de Investigación Sanitaria La Fe (ES)
Good health and well-being
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon